The role of BLyS/BLyS receptors in anti-chromatin B cell regulation

Int Immunol. 2007 Apr;19(4):465-75. doi: 10.1093/intimm/dxm011. Epub 2007 Mar 15.

Abstract

B lymphocyte stimulator (BLyS), also known as B cell-activating factor, is a key positive regulator of B cell homeostasis, and elevated levels of BLyS have been observed in systemic lupus erythematosus (SLE) patients. Given that anti-chromatin auto-antibodies are one of the hallmarks of SLE, we examined the role of BLyS and its receptors in the regulation of anti-chromatin B cells. We demonstrate that exogenous BLyS treatment leads to an increase in B cell numbers, particularly anti-chromatin B cells; yet, their localization in the spleen and auto-antibody production remain unaffected. We also examined transmembrane activator and CAML interactor (TACI), BLyS receptor 3 (BR3) and B cell maturation antigen expression on anti-chromatin B cells before and after receiving T cell help. Interestingly, in the absence of T cell help, TACI expression is greater on immature anti-chromatin B cells compared with immature Tg(-) B cells, whereas BR3 levels are comparable. After receiving T cell help, the anti-chromatin B cells that have differentiated into short-lived plasma cells no longer express BR3 but retain TACI. These data suggest a novel role for TACI in anti-chromatin B cell homeostasis and differentiation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adoptive Transfer
  • Animals
  • Antibodies, Antinuclear / blood
  • Antibodies, Antinuclear / immunology*
  • Antibody Formation / drug effects
  • Antibody Formation / immunology
  • B-Cell Activating Factor / pharmacology*
  • B-Cell Activation Factor Receptor / genetics
  • B-Cell Activation Factor Receptor / metabolism
  • B-Cell Maturation Antigen / genetics
  • B-Cell Maturation Antigen / metabolism
  • B-Lymphocyte Subsets / drug effects
  • B-Lymphocyte Subsets / immunology
  • B-Lymphocyte Subsets / metabolism
  • B-Lymphocytes / drug effects*
  • B-Lymphocytes / immunology
  • B-Lymphocytes / metabolism
  • Cell Differentiation / drug effects
  • Cell Differentiation / immunology
  • Female
  • Gene Expression
  • Hemagglutinin Glycoproteins, Influenza Virus / genetics
  • Hemagglutinin Glycoproteins, Influenza Virus / metabolism
  • Immunoglobulin Heavy Chains / genetics
  • Immunoglobulin kappa-Chains / genetics
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Mice, Transgenic
  • Receptors, CXCR5
  • Receptors, Chemokine / genetics
  • Receptors, Chemokine / metabolism
  • Receptors, Tumor Necrosis Factor / genetics
  • Receptors, Tumor Necrosis Factor / metabolism*
  • Spleen / cytology
  • Spleen / drug effects
  • Spleen / immunology
  • T-Lymphocytes, Helper-Inducer / immunology
  • T-Lymphocytes, Helper-Inducer / transplantation
  • Transmembrane Activator and CAML Interactor Protein / genetics
  • Transmembrane Activator and CAML Interactor Protein / metabolism

Substances

  • Antibodies, Antinuclear
  • B-Cell Activating Factor
  • B-Cell Activation Factor Receptor
  • B-Cell Maturation Antigen
  • BLyS receptor
  • CXCR5 protein, mouse
  • Hemagglutinin Glycoproteins, Influenza Virus
  • Immunoglobulin Heavy Chains
  • Immunoglobulin kappa-Chains
  • Receptors, CXCR5
  • Receptors, Chemokine
  • Receptors, Tumor Necrosis Factor
  • Tnfrsf13b protein, mouse
  • Tnfrsf17 protein, mouse
  • Transmembrane Activator and CAML Interactor Protein